As far as reviewing data before the testing is completely finished, that’s a possibility. Actually a great idea! Are they going to do that? Do you have any info?
FDA was a great obstacle in approving a drug in USA. They are overprotective. Because of FDA, we are not getting the newest medicines available. E.g. Voltaren gel was available in Europe over the counter dozen years ago for few bucks. They were even recommended it to pregnant women! While that, we were paying like $140 for prescription tube. Finally now it is over the counter for like $9.99. We still cannot buy the Max (double strength) version.
Trump is trying hard to change that!
Honestly, I was not a big Trump fan four years ago, but he really deliver! So many things has been done which should be done 47 years ago!
I’d be happy if the FDA would just stick to the same set of rules rather than changing them multiple times this year while there’s a pandemic that’s impacting the election and the potential to get multiple vaccines approved (through the normal process) and out the door to people.
But no, as soon as it looked like safe and effective vaccines might actually get approved before election day, the FDA suddenly found reasons why everyone had to halt all progress. Oxford? Well, one person in a totally different trial in the UK may have had a bad reaction. They’re fine now and the UK authorities allowed your trial to continue there, but how about we just hold you up for another month or two? Everyone else? Well hang on, we’ve got a whole new set of rules for trials. And we need to implement them right now. And you’ll need to halt all your trials and follow this whole new set of rules we’re making up on the spot. Good luck!